Efficacy of anti-TNF chimeric monoclonal antibody (Remicade) as induction therapy in Asian patients with active rheumatoid arthritis despite methotrexate treatment

被引:0
|
作者
Chow, SK
Ong, SG
Gun, SC
Rosman, A
Goh, EML
Quek, KF
机构
[1] Sunway Med Ctr, Petaling Jaya, Malaysia
[2] Selayang Hosp, Selayang, Malaysia
[3] Seremban Gen Hosp, Seremban, Malaysia
[4] Univ Malaya, Kuala Lumpur, Malaysia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:454 / +
页数:2
相关论文
共 50 条
  • [1] Onset of efficacy of anti-TNF alfa monoclonal antibody (remicade) in rheumatoid arthritis portuguese patients
    Vilar, A
    Araújo, D
    de Queiroz, MV
    Figueiredo, G
    Vaz, L
    André, R
    Moura, A
    Porto, A
    Quintal, A
    Branco, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 428 - 428
  • [2] Long-term control of signs and symptoms of rheumatoid arthritis with chimeric monoclonal anti-TNFα antibody (infliximab) in patients with active disease on methotrexate.
    Lipsky, P
    St Clair, W
    Kavanaugh, A
    McCune, W
    Smolen, J
    Breedveld, F
    Furst, D
    Kalden, J
    Weissman, M
    Braakman, T
    Schaible, T
    Maini, R
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S364 - S364
  • [3] Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy
    Bokarewa, M.
    Lindholm, C.
    Zendjanchi, K.
    Nadali, M.
    Tarkowski, A.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (04) : 476 - 483
  • [4] Combination therapy with the chimeric monoclonal antitumour necrosis factor infliximab (Remicade) plus methotrexate in rheumatoid arthritis patients
    Manger, B
    Dechant, B
    Antoni, C
    Kalden, JR
    [J]. AKTUELLE RHEUMATOLOGIE, 2001, 26 (04) : 159 - 161
  • [5] Chimeric anti-tumor necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
    Kavanaugh, A
    St Clair, EW
    McCune, WJ
    Braakman, T
    Lipsky, P
    [J]. JOURNAL OF RHEUMATOLOGY, 2000, 27 (04) : 841 - 850
  • [6] BONE LOSS IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANTI-TNF AND METHOTREXATE COMPARED WITH METHOTREXATE TREATMENT ALONE
    Vreju, F.
    Ciurea, P.
    Rosu, A.
    Florea, M.
    Musetescu, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 322 - 322
  • [7] 52-WEEK RESULTS OF CLINICAL, RADIOGRAPHIC AND PHARMACOKINETIC ASSESSMENTS: GOLIMUMAB, A HUMAN ANTI-TNF MONOCLONAL ANTIBODY, ADMINISTERED SUBCUTANEOUSLY EVERY FOUR WEEKS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Tanaka, Y.
    Harigai, M.
    Takeuchi, T.
    Yamanaka, H.
    Ishiguro, N.
    Yamamoto, K.
    Kanazawa, M.
    Murakami, Y.
    Yoshinari, T.
    Baker, D.
    Miyasaka, N.
    Koike, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 372 - 372
  • [8] 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy
    Tanaka, Yoshiya
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Kanazawa, Minoru
    Murakami, Yoshinori
    Yoshinari, Toru
    Baker, Daniel G.
    Miyasaka, Nobuyuki
    Koike, Takao
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S175 - S175
  • [9] Combination therapy of the chimeric monoclonal anti-tumor necrosis factor α antibody (infliximab) with methotrexate in patients with rheumatoid arthritis
    Antoni, C
    Kalden, JR
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S73 - S77
  • [10] RHEUMATOID ARTHRITIS Obesity impairs efficacy of anti-TNF therapy in patients with RA
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (11) : 641 - 642